Chanelle Wimbish

Also affiliated with University Research Co (United States)

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “QT effects of bedaquiline, delamanid, or both in patients with rifampicin-resistant tuberculosis: a phase 2, open-label, randomised, controlled trial”.

QT effects of bedaquiline, delamanid, or both in patients with rifampicin-resistant tuberculosis: a phase 2, open-label, randomised, controlled trial

The Lancet Infectious Diseases(2021)10.1016/s1473-3099(20)30770-2

N/A

4.9DataRank · unranked

124 citations

Susan L. Rosenkranz, Francesca Conradie, Laura Moran, Richard Hafner, Florian von Groote-Bidlingmaier +26 more

Safety and Immune Responses Following Anti-PD-1 Monoclonal Antibody Infusions in Healthy Persons With Human Immunodeficiency Virus on Antiretroviral Therapy

Open Forum Infectious Diseases(2024)10.1093/ofid/ofad694

N/A

0.553DataRank · unranked

14 citations

Ronald J. Bosch, Ashley McKhann, Raymond Cha, Gene D. Morse, Chanelle Wimbish +28 more

Short Course Therapy With Glecaprevir/Pibrentasvir for Early Hepatitis C Virus Infection: PURGE-C

Clinical Infectious Diseases(2025)10.1093/cid/ciaf305

N/A

0.104DataRank · unranked

1 citations

Min‐Hee Kang, Triin Umbleja, Estêvão Portela Nunes, Kristen Marks, Anne F. Luetkemeyer +67 more